ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer
By Stacy Simon The American Cancer Society has released a new Head and Neck Survivorship Care Guideline to help survivors of head and neck cancer and their primary care providers better manage their long-term care. The guideline addresses cancers of the oral cavity, tongue, lip, pharynx (throat), and larynx (voice box). Recommendations in the guideline may also apply to cancers of the salivary glands, nasal and paranasal sinuses, and nasopharynx. But it does not address cancers of the brain, thyroid, or esophagus because they are very different in terms of symptoms and treatment. RESOURCES: Head and Neck Cancer Survivor...
Source: American Cancer Society :: News and Features - March 23, 2016 Category: Cancer & Oncology Tags: Oral Cavity and Oropharyngeal Cancer Laryngeal and Hypopharyngeal Cancer Salivary Gland Cancer Nasal Cavity and Paranasal Sinus Cancer Nasopharyngeal Cancer Source Type: news
Head and neck cancer audit: large variances in survival rates reported
The national head and neck cancer audit has found that the four year crude survival rate from the head and neck group of cancers ranged from over 60% in patients diagnosed with cancer of the voice box (larynx) to only 33% in patients with cancer of the hypopharynx (the area where the larynx and oesophagus meet). (Source: NHS Networks)
Source: NHS Networks - October 9, 2015 Category: UK Health Source Type: news
Surgery Boosts Survival Chances for Advanced Throat CancerSurgery Boosts Survival Chances for Advanced Throat Cancer
Surgery significantly improves survival among patients with advanced oropharyngeal and hypopharyngeal cancers, registry data show. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 27, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Medrobotics wins FDA 510(k) for transoral surgery device
Medrobotics said today it won FDA 510(k) clearance for its Flex robotic transoral surgery system and is launching the system in the U.S. The Flex system uses a flexible robotic endoscope, a range of flexible instruments and a high-definition vision system for use in accessing and visualizing structures in the mouth and throat, Raynham, Mass.-based Medrobotics said. “The Flex robotic system is the 1st and only robot-assisted surgical platform with a flexible scope cleared by FDA for use during transoral procedures. The minimally invasive system enables surgical access and visualization in hard-to-reach locations ...
Source: Mass Device - July 23, 2015 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Robot-Assisted Surgery Surgical Medrobotics Source Type: news
EORTC head & neck cancer trial shows assessing HRQOL is valuable to both patients and their doctors
(European Organisation for Research and Treatment of Cancer) EORTC trial 24954 set out to compare two treatment schemes for patients with respectable hypopharyngeal and laryngeal cancers, and the results published in Cancer show that there is a trend towards worse HRQOL scores in patients receiving alternating chemoradiotherapy (alternating arm) as opposed to those given sequential induction chemotherapy and radiotherapy (sequential arm). However, very few differences reached the level of statistical significance, and most patients' HRQOL scores returned to baseline once treatment was completed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 20, 2013 Category: Cancer & Oncology Source Type: news